Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: Increased risk in the prediabetes phase

European Journal of Cancer Prevention

Volumn 23, Issue 2, 2014, Pages 76-83

  Onitilo, Adedayo A ^a   Stankowski, Rachel V ^a   Berg, Richard L ^a   Engel, Jessica M ^a   Glurich, Ingrid ^a   Williams, Gail M ^b   Doi, Suhail A R ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

breast cancer; cancer; diabetes mellitus; hyperinsulinaemia; incidence; insulin resistance; prediabetic state; risk; type 2

Indexed keywords

ADULT; AGE; AGED; ALGORITHM; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH INSURANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893802222     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32836162aa     Document Type: Article

References (24)

1. American Diabetes Association (2011). Standards of medical care in diabetes-2011. Diabetes Care 34:S11-S61.
2. Barratt AL,Wyer PC, Guyatt G, Simpson JM (2005). NNT for studies with longterm follow-up. Can Med Assoc J 172:613-615.
3. Bertram MY, Vos T (2010). Quantifying the duration of pre-diabetes. Aust N Z J Public Health 34:311-314.
4. Bowker SL, Richardson K, Marra CA, Johnson JA (2011). Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women. Diabetes Care 34:2542-2544.
5. Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. (2012). Diabetes and breast cancer risk: a meta-analysis. Br J Cancer 107: 1608-1617.
6. Carstensen B, Witte DR, Friis S (2011). Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 54:2263-2271.
7. Centers for Disease Control and Prevention (2011). Diabetes Report Card. National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation. Atlanta, GA. Available at: http://www.cdc.gov/diabetes/ pubs/pdf/DiabetesReportCard.pdf [Accessed 1 February 2012].
8. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998). Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120.
9. DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Cierkant RA, et al. (1996). Epidemiologic research in an integrative regional medical system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol 49:643-652.
10. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005). Metformin and reduced risk of cancer in diabetic patients. BMJ 330: 1304-1305.
11. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA 306:734-745.
12. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, et al. (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51.
13. Hardefeldt PJ, Edirimanne S, Eslick GD (2012). Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer 19:793-803.
14. Johnson JA, Bowker SL, Richardson K, Marra CA (2011). Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 54:2263-2271.
15. Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S (2011). Obesity and women's health: an evidence-based review. J Am Board Fam Med 24:75-85.
16. Larsson SC, Mantzoros CS,Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856-862.
17. Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, et al. (2011). Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev 12:1061-1065.
18. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006a). Increased prevalence of prior breast cancer in women with newly diagnosed diabetes. Breast Cancer Res Treat 98:303-309.
19. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006b). Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349-356.
20. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA (2012a). Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 23:967-981.
21. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA (2012b). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control 23:991-1008.
22. Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, Martin RM (2012). Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control 23:1785-1795.
23. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333.
24. Wilke RA, Berg RL, Peissig P, Kitchner T, Sijercic B, McCarty CA, et al. (2007). Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res 5:1-7.